Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Because severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS) rarely occur, clinical data based on large-scale studies are still lacking.

Objective: To provide information on culprit drugs and clinical characteristics, including morbidity and mortality of SCARs based on a nationwide registry.

Methods: SCAR cases that occurred from 2010 to 2015 were recruited to the Korean SCAR registry from 34 tertiary referral hospitals. Demographics, causative drugs, causality, and clinical outcomes were collected by reviewing the medical record.

Results: A total of 745 SCAR cases (384 SJS/TEN cases and 361 DRESS cases) due to 149 drugs were registered. The main causative drugs were allopurinol (14.0%), carbamazepine (9.5%), vancomycin (4.7%), and antituberculous agents (6.3%). A strong preference for SJS/TEN was observed in carbonic anhydrase inhibitors (100%), nonsteroidal anti-inflammatory drugs (84%), and acetaminophen (83%), whereas dapsone (100%), antituberculous agents (81%), and glycopeptide antibacterials (78%) were more likely to cause DRESS. The mortality rate was 6.6% (SJS/TEN 8.9% and DRESS 4.2%). The median time to death was 19 days and 29 days in SJS/TEN and DRESS respectively, and 89.8% of deaths occurred within 60 days after the onset of the skin symptoms.

Conclusion: Allopurinol, carbamazepine, vancomycin, and antituberculous agents were the leading causes of SCARs in Korea. Some drugs preferentially caused a specific phenotype. The mortality rate of SCARs was 6.6%, and most of the deaths occurred within 2 months.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2020.09.011DOI Listing

Publication Analysis

Top Keywords

antituberculous agents
12
severe cutaneous
8
cutaneous adverse
8
adverse reactions
8
scar cases
8
causative drugs
8
mortality rate
8
deaths occurred
8
drugs
6
dress
5

Similar Publications

Adverse effects of linezolid in the treatment of drug-resistant tuberculosis combined with diabetic peripheral neuropathy.

Eur J Med Res

August 2025

Department of Endocrinology, Hebei Provincial Key Laboratory of Pulmonary Diseases, Hebei Chest Hospital, Shijiazhuang, China.

Objective: This aimed to observe the adverse effects of linezolid on nerve conduction velocity in patients with drug-resistant tuberculosis combined with diabetic peripheral neuropathy.

Methods: Patients hospitalized in our hospital from March 2018 to March 2022 were divided into the drug-resistant tuberculosis (DRTB) group, type 2 diabetes peripheral neuropathy (DPN) group, and type 2 diabetic peripheral neuropathy combined with drug-resistant tuberculosis (DM-DRTB) group. The drug-resistant TB treatment regimen used linezolid with antituberculous drugs.

View Article and Find Full Text PDF

The World Health Organization (WHO) ranks tuberculosis (TB) as one of the top 10 causes of deaths worldwide. Notably, tobacco smoking represents a significant promoting factor in TB progression, being associated with poorer treatment outcomes, delayed conversion to negative smear or culture, and higher dropout rates from treatment plans. Remarkably, high rates of smoking and TB frequently overlaps in the same countries, warranting the need for targeted public health interventions.

View Article and Find Full Text PDF

Drug resistant tuberculous meningitis: A neglected foe in ending tuberculosis epidemic.

Indian J Tuberc

July 2025

Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India; ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.

Treatment outcomes of tuberculous meningitis (TBM), a disease with high mortality depends on early diagnosis and management. The global and regional burden of TBM and drug resistant TBM (DRTBM) are largely unknown. DRTBM is associated with poorer treatment outcomes.

View Article and Find Full Text PDF

Introduction: Prosthetic joint infections (PJIs) caused by mycobacteria are exceptionally rare and often underrecognized in clinical practice.

Areas Covered: Although most PJIs are due to common bacterial pathogens, and nontuberculous mycobacteria (NTM) represent a unique subset with distinct microbiological and therapeutic challenges. The presence of biofilms further complicates their management, often requiring intensive pharmacological interventions and surgical strategies.

View Article and Find Full Text PDF

Drug-induced acute kidney injury (AKI) is a rare adverse effect of rifampicin, and is mostly related to acute tubular necrosis and acute interstitial nephritis. We report a sputum- positive, isoniazid mono-resistant, pulmonary tuberculosis patient who had a history of anti-tuberculous therapy (ATT) intake 30 years ago. The patient developed AKI requiring dialysis when he restarted the ATT recently.

View Article and Find Full Text PDF